Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_assertion type Assertion NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_head.
- NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_assertion description "[These observations raise the possibility that application of PEDF may be helpful in designing new therapeutic strategies for neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, Alzheimer's disease and brain ischemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_provenance.
- NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_assertion evidence source_evidence_literature NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_provenance.
- NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_assertion SIO_000772 20236058 NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_provenance.
- NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_assertion wasDerivedFrom befree-20140225 NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_provenance.
- NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_assertion wasGeneratedBy ECO_0000203 NP927179.RAC-BV2Fm6FC-psh1rgp3WXcogTBaFQn942bYkBcGnKCE130_provenance.